Future Planet Capital
Investor profile
Future Planet Capital has backed 11 European tech companies across 11 funding rounds between 2017 and 2026, joining rounds totalling €72M. Most active in Healthtech and Agritech. Data as of 4 Nov 2026.
Deals
11
distinct rounds
Companies
11
backed
Active span
2017–2026
10 yrs
Total round €
€72M
sum of rounds joined
Deals by year
distinct rounds / yearFuture Planet Capital — deals by year — interactive chart.
Data table
| Future Planet Capital — deals by year | |
|---|---|
| 2017 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Top sectors
by dealsFuture Planet Capital — top sectors — interactive chart.
Data table
| Future Planet Capital — top sectors | |
|---|---|
| Healthtech | 3 |
| Agritech | 2 |
| Software | 2 |
| AI | 1 |
| Deeptech | 1 |
| Edtech | 1 |
| Foodtech | 1 |
Stages
by dealsFuture Planet Capital — stages — interactive chart.
Data table
| Future Planet Capital — stages | |
|---|---|
| Seed | 6 |
| Series A | 2 |
| Series B | 2 |
| Other | 1 |
Countries
by dealsFuture Planet Capital — countries — interactive chart.
Data table
| Future Planet Capital — countries | |
|---|---|
| UK | 11 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- The UK Innovation & Science Seed Fund (UKI2S)4
- Northern Gritstone2
- ACF investors1
- Alchimia1
- Amadeus Capital Partners1
- BGI Genomics (BGI)1
- British Business Bank Future Fund1
- C East X Ventures1
- Claire Davenport1
- E Ink1
- Empirical Ventures1
- Esco Lifesciences1
- Frontline Ventures1
- GK Goh1
- Healthlink Capital (Healthlink)1
- i&i Biotech Fund1
- Jason Stockwood1
- Joyful Ventures1
- Kairos Partners1
- London Co-Investment Fund1
- M&G Investments1
- Northern Universities Venture Fund1
- Novo Holdings1
- NPIF II – PXN Equity Finance1
- Nutreco1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nuclera | UK | 1 | €38M |
| Roslin Technologies | UK | 1 | €13M |
| Silveray | UK | 1 | €5.8M |
| Ternary Therapeutics | UK | 1 | €4.2M |
| Cytotrait | UK | 1 | €3.5M |
| Adamo Foods | UK | 1 | €2.3M |
| Cryogenx | UK | 1 | €1.9M |
| Astut | UK | 1 | €1.8M |
| Learberbly | UK | 1 | €1.8M |
| Navenio | UK | 1 | €1.1M |
| Congenica | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Nuclera | Series B | €38M | 2022-02 |
| Roslin Technologies | Series A | €13M | 2022-11 |
| Silveray | Other | €5.8M | 2026-06 |
| Ternary Therapeutics | Seed | €4.2M | 2026-03 |
| Cytotrait | Seed | €3.5M | 2026-03 |
| Adamo Foods | Seed | €2.3M | 2024-08 |
| Cryogenx | Seed | €1.9M | 2025-07 |
| Astut | Seed | €1.8M | 2025-10 |
| Learberbly | Seed | €1.8M | 2017-09 |
| Navenio | Series A | €1.1M | 2020-11 |